TipRanks
Hybrigenics SA Class A (DE:3HB)
STUTTGART:3HB
Germany Market

Hybrigenics SA Class A (3HB) Ratios

0 Followers

Hybrigenics SA Class A Ratios

DE:3HB's free cash flow for Q4 2022 was €0.00. For the 2022 fiscal year, DE:3HB's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.43 0.43 ― 0.18 1.73
Quick Ratio
0.43 0.43 ― 0.18 1.72
Cash Ratio
0.17 0.17 ― <0.01 0.22
Solvency Ratio
-0.03 -0.03 ― -1.04 -0.11
Operating Cash Flow Ratio
0.14 0.14 ― 0.00 0.00
Short-Term Operating Cash Flow Coverage
0.19 0.19 ― 0.00 0.00
Net Current Asset Value
€ -4.25M€ -4.25M€ ―€ -5.04M€ -221.05K
Leverage Ratios
Debt-to-Assets Ratio
0.85 0.85 ― 3.14 0.15
Debt-to-Equity Ratio
133.81 133.81 ― -0.69 0.22
Debt-to-Capital Ratio
0.99 0.99 ― -2.24 0.18
Long-Term Debt-to-Capital Ratio
0.97 0.97 ― 0.00 0.18
Financial Leverage Ratio
156.95 156.95 ― -0.22 1.49
Debt Service Coverage Ratio
-0.05 -0.05 ― 2.03 -0.22
Interest Coverage Ratio
-14.29 -14.29 ― -5.66 -10.43
Debt to Market Cap
0.26 0.53 ― 0.38 0.26
Interest Debt Per Share
<0.01 <0.01 ― <0.01 <0.01
Net Debt to EBITDA
-43.23 -43.23 ― -7.18 -3.23
Profitability Margins
Gross Profit Margin
74.28%74.28%―-38.14%-24685.83%
EBIT Margin
-132.83%-132.83%―-3485.50%-33068.33%
EBITDA Margin
-15.73%-15.73%―-117.42%-32547.95%
Operating Profit Margin
-121.03%-121.03%―-196.24%-37829.81%
Pretax Profit Margin
-141.30%-141.30%―-3520.15%-36694.62%
Net Profit Margin
-145.54%-145.54%―-4910.49%-36126.28%
Continuous Operations Profit Margin
-141.30%-141.30%―-4910.49%-36126.28%
Net Income Per EBT
103.00%103.00%―139.50%98.45%
EBT Per EBIT
116.75%116.75%―1793.78%97.00%
Return on Assets (ROA)
-16.57%-16.57%―-1828.06%-3.71%
Return on Equity (ROE)
-232.37%-2600.00%―402.20%-5.51%
Return on Capital Employed (ROCE)
-26.20%-26.20%―27.75%-4.73%
Return on Invested Capital (ROIC)
-14.96%-14.96%―-66.18%-3.95%
Return on Tangible Assets
-20.49%-20.49%―-2751.02%-3.78%
Earnings Yield
-10.05%-16.47%―-221.57%-3.33%
Efficiency Ratios
Receivables Turnover
1.70 1.70 ― 0.00 <0.01
Payables Turnover
1.31 1.31 ― 1.63 0.92
Inventory Turnover
0.00 0.00 ― 0.00 7.68
Fixed Asset Turnover
0.19 0.19 ― 32.13 0.08
Asset Turnover
0.11 0.11 ― 0.37 <0.01
Working Capital Turnover Ratio
-0.42 -0.42 ― -0.72 <0.01
Cash Conversion Cycle
-64.31 -64.31 ― -224.56 970.48K
Days of Sales Outstanding
214.80 214.80 ― 0.00 970.83K
Days of Inventory Outstanding
0.00 0.00 ― 0.00 47.50
Days of Payables Outstanding
279.12 279.12 ― 224.56 397.89
Operating Cycle
214.80 214.80 ― 0.00 970.88K
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 ― 0.00 0.00
Free Cash Flow Per Share
<0.01 <0.01 ― 0.00 0.00
CapEx Per Share
<0.01 <0.01 ― 0.00 0.00
Free Cash Flow to Operating Cash Flow
0.36 0.36 ― 0.00 0.00
Dividend Paid and CapEx Coverage Ratio
1.56 1.56 ― 0.00 0.00
Capital Expenditure Coverage Ratio
1.56 1.56 ― 0.00 0.00
Operating Cash Flow Coverage Ratio
0.08 0.08 ― 0.00 0.00
Operating Cash Flow to Sales Ratio
0.60 0.60 ― 0.00 0.00
Free Cash Flow Yield
1.19%2.43%―0.00%0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-11.80 -7.20 ― -0.45 -29.43
Price-to-Sales (P/S) Ratio
17.99 8.84 ― 22.16 10.84K
Price-to-Book (P/B) Ratio
258.71 157.86 ― -1.82 1.65
Price-to-Free Cash Flow (P/FCF) Ratio
83.74 41.13 ― 0.00 0.00
Price-to-Operating Cash Flow Ratio
24.30 14.82 ― 0.00 0.00
Price-to-Earnings Growth (PEG) Ratio
-0.12 0.14 ― >-0.01 0.10
Price-to-Fair Value
258.71 157.86 ― -1.82 1.65
Enterprise Value Multiple
-157.57 -99.39 ― -26.06 -36.55
Enterprise Value
16.39M 10.34M ― 11.74M 18.56M
EV to EBITDA
-157.57 -99.39 ― -26.06 -36.55
EV to Sales
24.79 15.64 ― 30.60 11.90K
EV to Free Cash Flow
115.40 72.79 ― 0.00 0.00
EV to Operating Cash Flow
41.59 26.24 ― 0.00 0.00
Tangible Book Value Per Share
>-0.01 >-0.01 ― -0.01 0.04
Shareholders’ Equity Per Share
<0.01 <0.01 ― -0.01 0.04
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 ― 0.54 0.02
Revenue Per Share
<0.01 <0.01 ― <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 ― -0.05 >-0.01
Tax Burden
1.03 1.03 ― 1.39 0.98
Interest Burden
1.06 1.06 ― 1.01 1.11
Research & Development to Revenue
0.00 0.00 ― 0.00 0.00
SG&A to Revenue
0.08 0.08 ― 0.00 129.62
Stock-Based Compensation to Revenue
0.00 0.00 ― 0.00 0.00
Income Quality
-0.39 -0.39 ― 0.00 0.00
Currency in EUR